Prospective Evaluation of Proteinuria and Renal Function in Diabetic Patients With Progressive Renal Disease

• Status: Completed
• Trial end date: 2009-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to evaluate the effects of Crestor (rosuvastatin) and (Lipitor) atorvastatin on urinary protein excretion over 1 year in patients with Type 1 or 2 diabetes with moderate proteinuria and hypercholesterolaemia.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: AstraZeneca
• Treatments: Atorvastatin; Atorvastatin Calcium; Rosuvastatin Calcium

Criteria

Inclusion Criteria:

• hyperlipidemia

• urinary protein

• diabetes

Exclusion Criteria:

• previous rosuvastatin treatment < 6 months prior to Visit 1

• statin intolerance

• severe hypertension